EE592 Long-Term Health and Economic Benefits of Switching to Tenofovir Alafenamide Versus Continuing on Entecavir in Chronic Hepatitis B Patients With Low-Level Viremia in Saudi Arabia

F Sanai, M Aljawad,AS Alghamdi, A Khathlan,M Alghamdi,S Kozma,N Smith,F El Moustaid,S Jeyakumar,N Kachru

Value in Health（2022）

引用 1|浏览1

暂无评分

摘要

This model found that switching to TAF versus remaining on ETV in SA CHB LLV patients substantially reduced long-term CHB-related morbidity and mortality and was a cost-effective treatment strategy.

查看译文

关键词

chronic hepatitis b,cost-effectiveness,markov state-transition model,tenofovir alafenamide

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要